See more : Indowind Energy Limited (INDOWIND.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Danimer Scientific, Inc. (DNMR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Danimer Scientific, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Value8 N.V. (VALUE.AS) Income Statement Analysis – Financial Results
- Niagara Mohawk Power Corporation PFD 3.40% (NMPWP) Income Statement Analysis – Financial Results
- United Airlines Holdings, Inc. (UAL) Income Statement Analysis – Financial Results
- Héroux-Devtek Inc. (HRX.TO) Income Statement Analysis – Financial Results
- Future Metals NL (FME.AX) Income Statement Analysis – Financial Results
Danimer Scientific, Inc. (DNMR)
About Danimer Scientific, Inc.
Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers. The company offers its products for biopolymers, including additives, aqueous coatings, fibers, filaments, films, thermoforming, and injection-molded articles. It also markets its products to consumer packaging brand owners, converters, and manufacturers in the plastics industry. Danimer Scientific, Inc. was founded in 2004 and is headquartered in Bainbridge, Georgia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 46.68M | 53.22M | 58.75M | 47.33M | 32.34M | 30.45M |
| Cost of Revenue | 73.64M | 63.63M | 57.87M | 35.88M | 21.24M | 19.21M |
| Gross Profit | -26.96M | -10.41M | 884.00K | 11.46M | 11.11M | 11.25M |
| Gross Profit Ratio | -57.75% | -19.57% | 1.50% | 24.21% | 34.34% | 36.92% |
| Research & Development | 29.24M | 31.94M | 20.27M | 7.85M | 5.48M | 5.14M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.26M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K |
| SG&A | 68.98M | 81.59M | 80.00M | 19.34M | 16.03M | 7.36M |
| Other Expenses | 434.00K | 723.00K | -44.00K | -31.00K | 277.00K | 0.00 |
| Operating Expenses | 98.66M | 113.53M | 100.27M | 27.19M | 21.51M | 8.11M |
| Cost & Expenses | 172.30M | 177.16M | 158.14M | 63.07M | 42.75M | 27.32M |
| Interest Income | 0.00 | 1.72M | 763.00K | 347.00K | 340.00K | 2.88M |
| Interest Expense | 0.00 | 112.25M | 763.00K | 2.43M | 3.48M | 0.00 |
| Depreciation & Amortization | 29.06M | 20.09M | 11.67M | 4.61M | 3.51M | 3.54M |
| EBITDA | -96.46M | -103.49M | -87.72M | -10.30M | -6.90M | 2.35M |
| EBITDA Ratio | -206.61% | -90.63% | -151.15% | -21.76% | -12.87% | 7.70% |
| Operating Income | -125.62M | -187.43M | -99.39M | -15.74M | -10.40M | -1.19M |
| Operating Income Ratio | -269.08% | -352.20% | -169.18% | -33.25% | -32.16% | -3.91% |
| Total Other Income/Expenses | -29.54M | 6.87M | 26.13M | 6.88M | -5.03M | -2.91M |
| Income Before Tax | -155.15M | -180.57M | -73.34M | -12.57M | -15.43M | 259.00K |
| Income Before Tax Ratio | -332.35% | -339.30% | -124.84% | -26.56% | -47.70% | 0.85% |
| Income Tax Expense | 319.00K | -810.00K | -13.23M | 2.40M | 4.09M | 51.00K |
| Net Income | -155.47M | -179.76M | -60.11M | -14.97M | -19.51M | 208.00K |
| Net Income Ratio | -333.03% | -337.78% | -102.31% | -31.62% | -60.33% | 0.68% |
| EPS | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
| EPS Diluted | -1.52 | -1.78 | -0.65 | -0.18 | -0.77 | 0.07 |
| Weighted Avg Shares Out | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.97M |
| Weighted Avg Shares Out (Dil) | 102.00M | 101.10M | 93.08M | 84.54M | 25.37M | 2.96M |
Danimer Scientific, Inc. (DNMR) CEO Stephen Croskrey on Q1 2022 Results - Earnings Call Transcript
Danimer Scientific, Inc. (NYSE:DNMR ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Russ Zukowski - VP, Corporate Finance Stephen Croskrey - CEO Michael Hajost - CFO Conference Call Participants Jon Tanwanteng - CJS Securities...
Danimer Scientific Announces First Quarter 2022 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today its financial results for the first quarter ended March 31, 2022. Stephen...
Danimer Scientific and Kemira Expand Exclusive Partnership to Commercialize Fully Biobased Barrier Coatings
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) and Kemira announced today a multi-year license and supply agreement, exclusive in Kemira's core markets, to commercialize biobased barrier coatings for paper and board products. The companies will introduce the newly developed...
Danimer Scientific Announces Date for First Quarter 2022 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2022 financial results after the...
Danimer Scientific Announces Date for First Quarter 2022 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today that the Company will release its first quarter 2022 financial results after the...
Danimer Scientific Appoints Anthony Austin as Chief Human Resource Officer
BAINBRIDGE, Ga.--(BUSINESS WIRE)---- $DNMR--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it has appointed Anthony Austin as Chief Human Resource Officer. In this...
Danimer Scientific: An Innovative Bioplastics Player With Huge Upside Potential
Strong industry tailwinds will bring about a huge demand for bioplastics, and with the current limited supply in the market, this bodes well for Danimer.
Danimer Scientific (DNMR) Stock: Why It Surged Today
The Danimer Scientific Inc (NYSE: DNMR) stock increased by over 18% during intraday trading today. This is why.
Danimer Scientific, Inc. (DNMR) CEO Stephen Croskrey on Q4 2021 Results - Earnings Call Transcript
Danimer Scientific, Inc. (DNMR) CEO Stephen Croskrey on Q4 2021 Results - Earnings Call Transcript
Danimer Scientific Announces Preliminary Fourth Quarter and Full Year 2021 Results
BAINBRIDGE, Ga.--(BUSINESS WIRE)--Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today its preliminary financial results for the fourth quarter and full year ended...
Source: https://incomestatements.info
Category: Stock Reports